Insuman Comb 30 Solostar

Insulin human, the active ingredient in Insuman Comb 30 Solostar, is an insulin presented as a solution for injection (prefilled pen) for subcutaneous use. It treats diabetes mellitus in both type 1 and type 2 patients.

GNH USA supplies Insuman Comb 30 Solostar as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insuman Comb 30 Solostar is an insulin preparation used in the management of diabetes mellitus and related insulin‑deficiency states. - Type 1 diabetes mellitus: provides rapid and intermediate insulin action to achieve glycaemic control. - Type 2 diabetes mellitus: supplements endogenous insulin to reach target blood glucose levels. - Basal‑bolus insulin regimens: combines short‑acting and protamine‑bound insulin to cover mealtime spikes and basal needs.

Common Side Effects: - Hypoglycaemia: symptoms of low blood sugar such as shakiness, sweating, and confusion. - Injection site reactions: redness, swelling, or itching at the injection site. - Lipodystrophy: localized changes in subcutaneous fat tissue. - Weight gain: increase in body weight associated with improved glycaemic control. - Localised allergic reactions: mild rash or urticaria. - Peripheral oedema: mild swelling of the extremities.

Serious or Rare Side Effects: - Severe hypoglycaemia: profound low glucose requiring assistance. - Anaphylaxis: life‑threatening systemic allergic reaction. - Insulin antibodies: may alter insulin action. - Hypokalaemia: low serum potassium levels. - Stevens‑Johnson syndrome: rare severe skin reaction. - Diabetic ketoacidosis: may occur if insulin is omitted.

Insuman Comb 30 Solostar requires careful clinical monitoring and patient education. - Dose titration: adjust based on regular blood glucose measurements. - Hypoglycaemia risk: ensure patients recognize symptoms and have rapid‑acting carbohydrate available. - Renal impairment: monitor kidney function and consider dose adjustments. - Pregnancy: use only when benefits outweigh potential risks. - Drug interactions: review all concomitant medications for additive hypoglycaemic potential. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 30 Solostar may interact with several drug classes. Major Interactions (Avoid): - Concurrent sulfonylureas: increased risk of severe hypoglycaemia. - Beta‑blockers: may mask typical hypoglycaemia warning signs. - Systemic corticosteroids: may necessitate higher insulin doses. Moderate Interactions (Monitor Closely): - ACE inhibitors: can potentiate insulin‑induced hypoglycaemia. - Thiazide diuretics: may affect glucose homeostasis. - Alcohol: can cause delayed hypoglycaemia, especially with binge drinking.